Year To Quarter End Consolidated Statement Of Income

Cyfuse Biomedical K.K. - Filing #7546761

Concept 2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
18,272,000 JPY
332,504,000 JPY
Cost of sales
8,691,000 JPY
120,751,000 JPY
Gross profit (loss)
9,580,000 JPY
211,752,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
57,937,000 JPY
57,900,000 JPY
Selling, general and administrative expenses
373,237,000 JPY
308,727,000 JPY
Operating profit (loss)
-363,656,000 JPY
-96,974,000 JPY
Non-operating income
Interest income
18,000 JPY
19,000 JPY
Non-operating income
11,060,000 JPY
29,566,000 JPY
Non-operating expenses
Interest expenses
4,987,000 JPY
2,735,000 JPY
Non-operating expenses
10,358,000 JPY
8,718,000 JPY
Ordinary profit (loss)
-362,953,000 JPY
-76,127,000 JPY
Extraordinary losses
Extraordinary losses
JPY
37,807,000 JPY
Profit (loss) before income taxes
-362,953,000 JPY
-113,934,000 JPY
Income taxes - current
1,652,000 JPY
1,004,000 JPY
Income taxes
1,652,000 JPY
1,004,000 JPY
Profit (loss)
-364,606,000 JPY
-114,938,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.